X
https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-q1-profit-slips-generic-competition-forex-effects-2024-04-25/
https://www.fiercebiotech.com/biotech/sanofi-pulls-phase-3-luna-landing-sparking-race-regulators-btk-inhibitor
https://www.novartis.com/news/media-releases/novartis-radioligand-therapy-lutathera-fda-approved-first-medicine-specifically-pediatric-patients-gastroenteropancreatic-neuroendocrine-tumors
https://www.fiercebiotech.com/biotech/sanofi-crosses-sjogrens-5b-drugs-hit-list-after-phase-2-data-disappoint
https://www.ausbiotech.org/news/ausbiotech-announces-incoming-ceo#:~:text=Australia's%20industry%20body%20for%20biotechnology,its%20incoming%20Chief%20Executive%20Officer.
https://www.globenewswire.com/news-release/2024/04/23/2867327/0/en/Press-Release-Rilzabrutinib-LUNA-3-phase-3-study-met-primary-endpoint-in-immune-thrombocytopenia.html
https://www.fiercepharma.com/pharma/sanofis-zantac-settlement-was-100m-or-25k-claimant-bloomberg-report
https://endpts.com/nvidias-biotech-moment-regeneron-launches-venture-arm-new-glp-1-player-enters-sanofi-rejigs-cancer-pact-vaccine-ops-and-more/
https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-overhaul-us-operations-vaccines-cut-jobs-2024-04-18/
https://www.fiercebiotech.com/biotech/sanofi-cuts-staff-belgium-early-stage-research-dwindles
Market Place
Share 
